Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

965 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study.
Horáková D, Kýr M, Havrdová E, Doležal O, Lelková P, Pospíšilová L, Bergsland N, Dwyer MG, Cox JL, Hussein S, Seidl Z, Vaněčková M, Krásenský J, Zivadinov R. Horáková D, et al. Among authors: hussein s. Folia Biol (Praha). 2010;56(6):242-51. Folia Biol (Praha). 2010. PMID: 21324265 Free article.
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.
Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R. Horakova D, et al. Among authors: hussein s. J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):407-14. doi: 10.1136/jnnp.2007.120378. Epub 2007 Jun 5. J Neurol Neurosurg Psychiatry. 2008. PMID: 17550987 Clinical Trial.
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
Havrdova E, Zivadinov R, Krasensky J, Dwyer MG, Novakova I, Dolezal O, Ticha V, Dusek L, Houzvickova E, Cox JL, Bergsland N, Hussein S, Svobodnik A, Seidl Z, Vaneckova M, Horakova D. Havrdova E, et al. Among authors: hussein s. Mult Scler. 2009 Aug;15(8):965-76. doi: 10.1177/1352458509105229. Epub 2009 May 22. Mult Scler. 2009. PMID: 19465443 Clinical Trial.
HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event.
Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, Ramanathan M. Horakova D, et al. Among authors: hussein s. J Neuroimmunol. 2011 Jul;236(1-2):76-80. doi: 10.1016/j.jneuroim.2011.04.011. Epub 2011 May 31. J Neuroimmunol. 2011. PMID: 21621859 Clinical Trial.
Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study.
Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Qu J, Tamaño-Blanco M, Badgett D, Tyblova M, Bergsland N, Hussein S, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, Dwyer MG, Zhang M, Yu H, Duan X, Kalincik T, Ramanathan M. Horakova D, et al. Among authors: hussein s. PLoS One. 2013;8(1):e53996. doi: 10.1371/journal.pone.0053996. Epub 2013 Jan 8. PLoS One. 2013. PMID: 23320113 Free PMC article. Clinical Trial.
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.
Weinstock-Guttman B, Zivadinov R, Horakova D, Havrdova E, Qu J, Shyh G, Lakota E, O'Connor K, Badgett D, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Ramanathan M. Weinstock-Guttman B, et al. Among authors: hussein s. J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1186-91. doi: 10.1136/jnnp-2012-304740. Epub 2013 Apr 17. J Neurol Neurosurg Psychiatry. 2013. PMID: 23595944
Gender-related differences in MS: a study of conventional and nonconventional MRI measures.
Antulov R, Weinstock-Guttman B, Cox JL, Hussein S, Durfee J, Caiola C, Dwyer MG, Bergsland N, Abdelrahman N, Stosic M, Hojnacki D, Munschauer FE, Miletic D, Zivadinov R. Antulov R, et al. Among authors: hussein s. Mult Scler. 2009 Mar;15(3):345-54. doi: 10.1177/1352458508099479. Epub 2008 Nov 21. Mult Scler. 2009. PMID: 19028830
Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years.
Zivadinov R, Bergsland N, Dolezal O, Hussein S, Seidl Z, Dwyer MG, Vaneckova M, Krasensky J, Potts JA, Kalincik T, Havrdová E, Horáková D. Zivadinov R, et al. Among authors: hussein s. AJNR Am J Neuroradiol. 2013 Oct;34(10):1931-9. doi: 10.3174/ajnr.A3503. Epub 2013 Apr 11. AJNR Am J Neuroradiol. 2013. PMID: 23578679 Free PMC article. Clinical Trial.
965 results